Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA
- PMID: 2436053
- DOI: 10.1038/326414a0
Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA
Erratum in
- Nature 1987 Apr 23-29;326(6115):812
Abstract
Yeast strains with mutations in the genes for DNA topoisomerases I and II have been identified previously in both Saccharomyces cerevisiae and Schizosaccharomyces pombe. The topoisomerase II mutants (top2) are conditional-lethal temperature-sensitive (ts) mutants. They are defective in the termination of DNA replication and the segregation of daughter chromosomes, but otherwise appear to replicate and transcribe DNA normally. Topoisomerase I mutants (top1), including strains with null mutations are viable and exhibit no obvious growth defects, demonstrating that DNA topoisomerase I is not essential for viability in yeast. In contrast to the single mutants, top1 top2 ts double mutants from both Schizosaccharomyces pombe and Saccharomyces cerevisiae grow poorly at the permissive temperature and stop growth rapidly at the non-permissive temperature. Here we report that DNA and ribosomal RNA synthesis are drastically inhibited in an S. cerevisiae top1 top2 ts double mutant at the restrictive temperature, but that the rate of poly(A)+ RNA synthesis is reduced only about threefold and transfer DNA synthesis remains relatively normal. The results suggest that DNA replication and at least ribosomal RNA synthesis require an active topoisomerase, presumably to act as a swivel to relieve torsional stress, and that either topoisomerase can perform the required function (except in termination of DNA replication where topoisomerase II is required).
Similar articles
-
DNA topoisomerase activity is required as a swivel for DNA replication and for ribosomal RNA transcription.NCI Monogr. 1987;(4):11-5. NCI Monogr. 1987. PMID: 2442627
-
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.Mol Pharmacol. 1988 Dec;34(6):755-60. Mol Pharmacol. 1988. PMID: 2849043
-
Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.Cancer Res. 1994 Apr 1;54(7):1795-800. Cancer Res. 1994. PMID: 8137294
-
Ribonucleotides and Transcription-Associated Mutagenesis in Yeast.J Mol Biol. 2017 Oct 27;429(21):3156-3167. doi: 10.1016/j.jmb.2016.08.005. Epub 2016 Aug 7. J Mol Biol. 2017. PMID: 27511624 Free PMC article. Review.
-
Mechanisms of DNA topoisomerase I-induced cell killing in the yeast Saccharomyces cerevisiae.Ann N Y Acad Sci. 2000;922:65-75. doi: 10.1111/j.1749-6632.2000.tb07026.x. Ann N Y Acad Sci. 2000. PMID: 11193926 Review.
Cited by
-
Unusual enhancer function in yeast rRNA transcription.Mol Cell Biol. 1989 Nov;9(11):4986-93. doi: 10.1128/mcb.9.11.4986-4993.1989. Mol Cell Biol. 1989. PMID: 2689870 Free PMC article.
-
Developmental regulation of Drosophila DNA topoisomerase II.J Cell Biol. 1991 Jan;112(2):203-13. doi: 10.1083/jcb.112.2.203. J Cell Biol. 1991. PMID: 1846370 Free PMC article.
-
The SR protein B52/SRp55 is required for DNA topoisomerase I recruitment to chromatin, mRNA release and transcription shutdown.PLoS Genet. 2010 Sep 16;6(9):e1001124. doi: 10.1371/journal.pgen.1001124. PLoS Genet. 2010. PMID: 20862310 Free PMC article.
-
Modeling of DNA local parameters predicts encrypted architectural motifs in Xenopus laevis ribosomal gene promoter.Nucleic Acids Res. 2000 Sep 15;28(18):3433-41. doi: 10.1093/nar/28.18.3433. Nucleic Acids Res. 2000. PMID: 10982860 Free PMC article.
-
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer.Oncologist. 2019 Dec;24(12):1512-e1267. doi: 10.1634/theoncologist.2019-0516. Epub 2019 Aug 5. Oncologist. 2019. PMID: 31383812 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
